Kiyatec Inc.

The future of brain cancer care is here, and we're bringing it to Houston! Kiyatec is thrilled to be at the 29th Annual SNO Meeting & Education Day at booth #117/216, sharing how 3D Predict? is answering the question that matters most to patients, "Will this chemo work?" Take a sneak peek at what we do at: bit.ly/3DPredictHCP #Kiyatec #3DPredict #FunctionalPrecisionOncology #Glioma #SNO2024 #NeuroOncology #HealthcareConferences

Patients are stronger than you think. ?? Some patients don't want to know everything, but others want to know every detail when it comes to their cancer. And although oncologists should always be mindful of their bedside manner, they should also be straightforward about what their patients are facing, as it will help them in their decision-making moving forward. With 3D Predict?, we're helping to make that conversation easier by telling #Oncologists what drugs will (or won't) work for their patients' cancer. Learn more here: bit.ly/3DPredictPatient #Kiyatec #3DPredict #FunctionalPrecisionOncology #Oncologists #BedsideManner #TreatmentPlan #PatientCare

"Can my cancer type be treated?" This is likely the number one question your patients want answered. We will continue developing other 3D Predict? tests that will help oncologists give patients confident answers about their treatment options. #Kiyatec #3DPredict #FunctionalPrecisionOncology #Oncologists #CancerTreatment #PatientCare #PatientAdvocacy

Is our glioma test really that easy? ?? It sure is. See for yourself. "We take a portion of the live tumor tissue, about 1.1 gram, that you send to our CLIA-certified laboratory where 600 to 1,000 steroids are created. Then we introduce 12 potential therapies to directly interact with your patient's live tissues. We measure the response and within 7 to 10 days, you receive a report indicating which drugs responded to their cancer cells. This gives the oncology team and the patient a better road map as they enter this journey. We like to say if it dies in the laboratory, we're predicting it should die in the patient's body." ~CEO Eric Perreault Your patients want a treatment road map, and we can help you give it to them. See how 3D Predict? works. bit.ly/3DPredictVideo #Kiyatec #3DPredict #FunctionalPrecisionOncology #BrainTumor #CellCultureTechnology #3DCellCulture #PersonalizedCare #TreatmentOptions

#DYK that more people will die of lung cancer this year than breast, colon, and prostate cancers combined? About 65,790 men and 59,280 women to be exact. Lung cancers can be just as aggressive as brain cancer — that's why we're committed to bringing you 3D Predict? for primary lung cancer as well as brain metastasis lung cancer in the not so distant future. Stay up to date here: bit.ly/3DPPlatform #Kiyatec #3DPredict #FunctionalPrecisionOncology #LungCancer #LungCancerAwarenessMonth #CancerAwareness #StandUpToCancer

At least 25 healthcare systems have sent in tissue from their patients' tumors so they can find out which drug will kill their cancer in our lab. Will your healthcare system be next? ?? Take a peek at how it works here and let's talk: bit.ly/3DPredictVideo #NewTechnology #3DPredict #Kiyatec #FunctionalPrecisionOncology #HealthcareSystems #CancerTherapy #Chemotherapy #PatientCare #BrainTumors

When our 3D Predict? test shows a response, it’s because the chemo actually killed that patient's live cancer cells. "If 3D Predict shows that your patient responds to a particular chemotherapy, then that response means it killed the patient's cancer in our lab. The accuracy of that result should give oncologists great confidence in our test." — CEO Eric Perreault ?? Discover how 3D Predict can transform your treatment approach at: bit.ly/Glioma #Kiyatec #3DPredict #FunctionalPrecisionOncology #BrainTumor #HighGradeGlioma

We know that the survival window for HGG patients can be short due to the limited treatment advancements over the past few decades. That's why we created 3D Predict? Glioma. This test offers a new way forward by identifying individual responses to standard-of-care treatments like temozolomide (TMZ) before treatment begins. It will show with 98% certainty which chemo will (or won't) kill a patient's cancer cells so different treatment possibilities may be considered — whether it's: ?? An alternative chemotherapy, ?? clinical trial, or ?? no treatment at all. See how our functional precision oncology test prospectively identifies patients' response to TMZ in this recent study: go.nature.com/3XrcTpF #Kiyatec #3DPredict #FunctionalPrecisionOncology #Temozolomide #RadiationTherapy #OncologyInnovation #StandardOfCare #SurvivalRate #PatientAdvocacy #PatientSupport #PatientCare #QualityOfLife

Neuro-oncologists must keep their patients' priorities in mind when determining their treatment plan. Whether it's their desire to attend the wedding of their child or complete a bucket list item, this is part of the overall conversation. With 3D Predict?, you have another tool to help patients plan for the future should the typical standard of care not work. We think this test should be a first step for all HGG patients. bit.ly/3DPredictHCP #Kiyatec #FunctionalPrecisionOncology #BrainCancer #HighGradeGlioma #CancerResearch #Oncologists #OncologyInnovation #TreatmentPlan #StandardOfCare #PatientSupport

Using standard-of-care TMZ + radiation to treat patients with HGG will typically only increase their survival rate by 2.5 months? But a recent study (go.nature.com/3XrcTpF) reveals that using the 3D Predict? Glioma test prior to therapy, results in a significant increase in progression-free survival for predicted TMZ responders vs. nonresponders: ? 5.8 months for HGG patients ? 4.7 months for glioblastoma patients ? 4.7 months for those with MGMT unmethylated glioblastoma #3DPredict is crucial for tailoring effective treatment and it's changing the landscape of glioma care. By creating personalized treatment plans based on the results of this test, patients can have more time to achieve goals or make the most of the time they have left. ??Let us help you and your patients make more informed decisions about their treatment: bit.ly/3DPredictGlioma #Kiyatec #FunctionalPrecisionOncology #Temozolomide #RadiationTherapy #BrainCancer #Glioblastoma #HighGradeGlioma #CancerResearch #StandardOfCare #SurvivalRate